MC2188A1 - Diagnostic du nanbv:polynucleotides permettant de depister le virus de l'hepatite c - Google Patents
Diagnostic du nanbv:polynucleotides permettant de depister le virus de l'hepatite cInfo
- Publication number
- MC2188A1 MC2188A1 MC@@@@@@@@@@@@D MC2188D MC2188A1 MC 2188 A1 MC2188 A1 MC 2188A1 MC 2188 D MC2188 D MC 2188D MC 2188 A1 MC2188 A1 MC 2188A1
- Authority
- MC
- Monaco
- Prior art keywords
- virus
- hepatitis
- polynucleotides
- nanbv
- diagnosis
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title abstract 5
- 102000040430 polynucleotide Human genes 0.000 title abstract 4
- 108091033319 polynucleotide Proteins 0.000 title abstract 4
- 239000002157 polynucleotide Substances 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000010710 hepatitis C virus infection Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35596189A | 1989-05-18 | 1989-05-18 | |
US45663789A | 1989-12-21 | 1989-12-21 | |
US50543590A | 1990-04-04 | 1990-04-04 | |
PCT/US1990/002853 WO1990014436A1 (fr) | 1989-05-18 | 1990-05-18 | Diagnostic du nanbv (virus de l'hepatite non-a et non-b): polynucleotides utiles pour depister le virus de l'hepatite c |
Publications (1)
Publication Number | Publication Date |
---|---|
MC2188A1 true MC2188A1 (fr) | 1992-09-16 |
Family
ID=27408242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MC@@@@@@@@@@@@D MC2188A1 (fr) | 1989-05-18 | 1990-05-18 | Diagnostic du nanbv:polynucleotides permettant de depister le virus de l'hepatite c |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0398748B1 (fr) |
JP (3) | JP2656996B2 (fr) |
AT (1) | ATE211772T1 (fr) |
AU (1) | AU638719B2 (fr) |
BG (1) | BG60348B2 (fr) |
CA (1) | CA2017157C (fr) |
DE (1) | DE69033891T2 (fr) |
DK (1) | DK0398748T3 (fr) |
ES (1) | ES2166749T3 (fr) |
FI (1) | FI105279B (fr) |
GE (1) | GEP20002164B (fr) |
HU (1) | HUT59964A (fr) |
LV (1) | LV10729B (fr) |
MC (1) | MC2188A1 (fr) |
NO (1) | NO303503B1 (fr) |
RO (1) | RO113059B1 (fr) |
WO (1) | WO1990014436A1 (fr) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6489246A (en) * | 1987-09-30 | 1989-04-03 | Sony Corp | Fixing method for color sorting mechanism of color cathode-ray tube |
US6861212B1 (en) | 1987-11-18 | 2005-03-01 | Chiron Corporation | NANBV diagnostics and vaccines |
US5714596A (en) * | 1987-11-18 | 1998-02-03 | Chiron Corporation | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus |
US5698390A (en) * | 1987-11-18 | 1997-12-16 | Chiron Corporation | Hepatitis C immunoassays |
US6171782B1 (en) | 1987-11-18 | 2001-01-09 | Chiron Corporation | Antibody compositions to HCV and uses thereof |
US5712088A (en) * | 1987-11-18 | 1998-01-27 | Chiron Corporation | Methods for detecting Hepatitis C virus using polynucleotides specific for same |
US6027729A (en) * | 1989-04-20 | 2000-02-22 | Chiron Corporation | NANBV Diagnostics and vaccines |
ES2029171A6 (es) * | 1989-12-18 | 1992-07-16 | Wellcome Found | Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh) |
US7166287B1 (en) | 1989-12-18 | 2007-01-23 | Glaxo Wellcome Inc. | Viral agent |
EP0461863A1 (fr) * | 1990-06-12 | 1991-12-18 | Immuno Japan Inc. | Amorces oligonucléotidiques et leur utilisation pour la détection de non-A, non-B virus d'hépatite à haute fidélité |
US5747339A (en) * | 1990-06-25 | 1998-05-05 | Research Foundation For Microbial Diseases Of Osaka | Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide |
JPH05508318A (ja) * | 1990-06-30 | 1993-11-25 | アクゾ・エヌ・ヴエー | 非―a非―b配列 |
ATE150086T1 (de) * | 1990-07-11 | 1997-03-15 | Shionogi & Co | Cdns-sequenz und detektion des hepatitis c-virus |
WO1992001714A1 (fr) * | 1990-07-24 | 1992-02-06 | Yamanouchi Pharmaceutical Co., Ltd. | Antigene du virus de l'hepatite non a, non b |
CZ282573B6 (cs) * | 1990-08-10 | 1997-08-13 | Chiron Corporation | Způsob detekce HCV sekvence, souprava a reakční činidlo pro detekci HCV |
WO1992009634A1 (fr) * | 1990-11-29 | 1992-06-11 | Toray Industries, Incorporated | Proteine anti-genique du virus de l'hepatite non a et non b |
WO1992012992A2 (fr) * | 1991-01-14 | 1992-08-06 | James N. Gamble Institute Of Medical Research | Polypeptides immunogeniques structuraux de base ayant des epitopes pour vhc, anticorps, sequences de polynucleotides, vaccins et methodes |
ATE112782T1 (de) * | 1991-03-01 | 1994-10-15 | Akzo Nobel Nv | Mit antikörper gegen hepatitis non-a, non-b-virus immunochemische reaktive peptide. |
US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
EP0510952A1 (fr) * | 1991-04-26 | 1992-10-28 | Immuno Japan Inc. | Primaires d'oligonucleotides et leur application de détection à haut détail de non-A, non-B hepatitis |
FR2677372B1 (fr) * | 1991-06-06 | 1994-11-10 | Pasteur Institut | Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques. |
IT1249684B (it) * | 1991-07-19 | 1995-03-09 | Sorin Biomedica Spa | Epitopi della proteina env del virus dell'epatite c. |
ES2198514T3 (es) * | 1991-08-27 | 2004-02-01 | F. Hoffmann-La Roche Ag | Cebadores y sondas para la deteccion de la hepatitis c. |
JPH06502770A (ja) * | 1991-09-12 | 1994-03-31 | シーダーズ−サイナイ・メディカル・センター | C型肝炎ウイルスrnaの直接検出法 |
JPH06511149A (ja) * | 1991-09-13 | 1994-12-15 | カイロン コーポレイション | 免疫反応性c型肝炎ウイルスのポリペプチド組成物 |
CA2099883A1 (fr) * | 1991-11-07 | 1993-05-08 | John A. Kink | Cartographie de l'epitope de la region c33c du vhc |
JP3688290B2 (ja) * | 1991-11-21 | 2005-08-24 | コモン サーヴィシス エージェンシー | C型肝炎ウイルス検査 |
GB9204274D0 (en) * | 1992-02-28 | 1992-04-08 | Wellcome Found | Novel peptides |
US5866139A (en) * | 1992-06-04 | 1999-02-02 | Institut Pasteur | Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
US5922857A (en) * | 1992-09-28 | 1999-07-13 | Chiron Corporation | Methods and compositions for controlling translation of HCV proteins |
JPH06153961A (ja) * | 1992-11-27 | 1994-06-03 | Imuno Japan:Kk | C型肝炎ウイルス部分遺伝子、ならびにc型肝炎ウイルス遺 伝子の高感度検出法 |
EP0697888B1 (fr) | 1993-05-12 | 2003-09-17 | Chiron Corporation | Motif conserve de la region e2/ns1 du virus de l'hepatite c |
CA2195312A1 (fr) | 1994-07-29 | 1996-02-15 | Mark Selby | Nouveaux polypeptides a troncature e1 et e2 de l'hepatite c et procede d'obtention de ces derniers |
WO1996004301A2 (fr) * | 1994-07-29 | 1996-02-15 | Chiron Corporation | Nouveaux polypeptides a troncature e1 et e2 de l'hepatite c et procede d'obtention de ces derniers |
US5837442A (en) | 1995-11-29 | 1998-11-17 | Roche Molecular Systems, Inc. | Oligonucleotide primers for amplifying HCV nucleic acid |
EP0980434B1 (fr) | 1997-05-06 | 2009-07-29 | Novartis Vaccines and Diagnostics, Inc. | Production intracellulaire d'un polypeptide e2 tronque dirige contre l'hepatite c |
DE19832050C2 (de) * | 1998-07-16 | 2002-10-10 | Biotest Pharma Gmbh | Verfahren zum Nachweis von Hepatitis B- bzw. Hepatitis C-Virusgenomen in Plasmaproben und spezifische Primer |
JP2002537355A (ja) | 1999-02-26 | 2002-11-05 | カイロン コーポレイション | 抗原の粘膜送達のための生体接着剤およびアジュバントの使用 |
CA2689696C (fr) | 1999-02-26 | 2013-08-06 | Novartis Vaccines And Diagnostics, Inc. | Microemulsions a macromolecules et microparticules adsorbees |
US7196066B1 (en) | 1999-11-03 | 2007-03-27 | Powderject Vaccines, Inc. | DNA-vaccines based on constructs derived from the genomes of human and animal pathogens |
SI1354204T2 (sl) * | 2000-06-15 | 2010-09-30 | Novartis Vaccines & Diagnostic | Hcv antigen antitelo kombinacijska analiza |
US6680059B2 (en) | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
US6858590B2 (en) | 2000-08-17 | 2005-02-22 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
CA2419418A1 (fr) | 2000-08-17 | 2002-02-21 | Tripep Ab | Vaccins contenant de la ribavirine et procedes d'utilisation associes |
US7022830B2 (en) | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
US6586584B2 (en) | 2001-01-29 | 2003-07-01 | Becton, Dickinson And Company | Sequences and methods for detection of Hepatitis C virus |
CA2448066A1 (fr) | 2001-05-31 | 2002-12-12 | Chiron Corporation | Particules de replicon d'alphavirus chimerique |
AR045702A1 (es) | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
CA2476626A1 (fr) | 2002-02-20 | 2003-08-28 | Chiron Corporation | Microparticules comprenant des molecules adsorbees qui contiennent polypeptides |
US7598421B2 (en) | 2002-05-08 | 2009-10-06 | Ucl Biomedica Plc | Materials for the delivery of biologically-active material to cells |
WO2004060396A2 (fr) | 2002-12-27 | 2004-07-22 | Chiron Corporation | Immunogenes contenant des compositions de phospholipide |
WO2004084936A2 (fr) | 2003-02-06 | 2004-10-07 | Cerus Corporation | Microbes modifies vivant en milieu naturel, compositions de vaccins, et procedes d'utilisation correspondants |
US7695725B2 (en) | 2003-02-06 | 2010-04-13 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
ES2382332T3 (es) | 2003-02-06 | 2012-06-07 | Aduro Biotech | Listeria atenuada para entrar en células no fagocíticas, vacunas que comprenden esta listeria y métodos de uso de las mismas |
US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
EP1784211A4 (fr) | 2004-07-29 | 2010-06-30 | Novartis Vaccines & Diagnostic | Compositions immunogenes pour bacteries a gram positif telles que streptococcus agalactiae |
ES2377978T3 (es) | 2004-08-27 | 2012-04-03 | Novartis Vaccines And Diagnostics, Inc. | Mutantes de proteínas no estructurales de VHC y usos de los mismos |
WO2007031867A2 (fr) | 2005-05-25 | 2007-03-22 | Tripep Ab | Gene de fusion ns3/4a non structurel de l'hepatite c |
EP2121991A2 (fr) * | 2006-10-20 | 2009-11-25 | Innogenetics N.V. | Méthode d'analyse des mutations |
US8071561B2 (en) | 2007-08-16 | 2011-12-06 | Chrontech Pharma Ab | Immunogen platform |
WO2009076158A1 (fr) | 2007-12-07 | 2009-06-18 | Novartis Ag | Compositions utilisées pour induire des réponses immunitaires |
WO2009130588A2 (fr) | 2008-04-22 | 2009-10-29 | Tripep Ab | Plateforme immunogène |
CN102076843A (zh) | 2008-05-19 | 2011-05-25 | 艾杜罗生物科技公司 | 包含prfa*突变体李斯特菌的组合物及其使用方法 |
WO2010103017A2 (fr) | 2009-03-09 | 2010-09-16 | William Henry | Conjugués haptène-support liés à des toxines bactériennes et ayant un peptide signal comme support, et leur utilisation dans des compositions immunogènes |
FI122954B (fi) | 2011-01-31 | 2012-09-14 | Teknoware Oy | LED-putkilamppu ja valaisinjärjestely |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
CN1074422C (zh) * | 1987-11-18 | 2001-11-07 | 希龙股份有限公司 | 制备含有hcv表位的分离多肽的方法 |
US5191064A (en) * | 1988-09-30 | 1993-03-02 | The Research Foundation For Microbial Diseases (Osaka University) | Non-a, non-b hepatitis virus antigen peptide |
HU225068B1 (en) * | 1989-03-17 | 2006-05-29 | Chiron Corp | Process for producing diagnostics and vaccine of nanbh |
AU638304B2 (en) * | 1989-12-22 | 1993-06-24 | Abbott Laboratories | Hepatitis c assay |
AU7672991A (en) * | 1990-04-03 | 1991-10-30 | Southwest Foundation For Biomedical Research | Purified hcv and hcv proteins and peptides |
-
1990
- 1990-05-18 MC MC@@@@@@@@@@@@D patent/MC2188A1/fr unknown
- 1990-05-18 AU AU58123/90A patent/AU638719B2/en not_active Expired
- 1990-05-18 GE GE1876A patent/GEP20002164B/en unknown
- 1990-05-18 HU HU904754A patent/HUT59964A/hu unknown
- 1990-05-18 AT AT90305421T patent/ATE211772T1/de not_active IP Right Cessation
- 1990-05-18 DE DE69033891T patent/DE69033891T2/de not_active Expired - Lifetime
- 1990-05-18 DK DK90305421T patent/DK0398748T3/da active
- 1990-05-18 EP EP90305421A patent/EP0398748B1/fr not_active Expired - Lifetime
- 1990-05-18 WO PCT/US1990/002853 patent/WO1990014436A1/fr active IP Right Grant
- 1990-05-18 JP JP2508534A patent/JP2656996B2/ja not_active Expired - Lifetime
- 1990-05-18 CA CA002017157A patent/CA2017157C/fr not_active Expired - Lifetime
- 1990-05-18 ES ES90305421T patent/ES2166749T3/es not_active Expired - Lifetime
- 1990-05-18 RO RO149205A patent/RO113059B1/ro unknown
-
1991
- 1991-11-18 FI FI915443A patent/FI105279B/fi active
- 1991-11-18 NO NO914517A patent/NO303503B1/no not_active IP Right Cessation
- 1991-11-18 BG BG95495A patent/BG60348B2/bg unknown
-
1993
- 1993-06-01 LV LVP-93-456A patent/LV10729B/en unknown
-
1996
- 1996-10-30 JP JP30570796A patent/JP3701754B2/ja not_active Expired - Lifetime
-
1997
- 1997-05-19 JP JP14598597A patent/JP3698520B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2166749T3 (es) | 2002-05-01 |
BG60348B2 (bg) | 1994-06-30 |
LV10729B (en) | 1995-12-20 |
FI915443A0 (fi) | 1991-11-18 |
ATE211772T1 (de) | 2002-01-15 |
NO914517L (no) | 1992-01-16 |
CA2017157C (fr) | 2003-07-29 |
AU5812390A (en) | 1990-12-18 |
JP3701754B2 (ja) | 2005-10-05 |
NO303503B1 (no) | 1998-07-20 |
HU904754D0 (en) | 1992-01-28 |
JP2656996B2 (ja) | 1997-09-24 |
FI105279B (fi) | 2000-07-14 |
WO1990014436A1 (fr) | 1990-11-29 |
JPH05500155A (ja) | 1993-01-21 |
AU638719B2 (en) | 1993-07-08 |
EP0398748B1 (fr) | 2002-01-09 |
DK0398748T3 (da) | 2002-03-18 |
JPH1089A (ja) | 1998-01-06 |
HUT59964A (en) | 1992-07-28 |
RO113059B1 (ro) | 1998-03-30 |
DE69033891D1 (de) | 2002-02-21 |
DE69033891T2 (de) | 2002-08-29 |
LV10729A (lv) | 1995-06-20 |
JPH10113176A (ja) | 1998-05-06 |
EP0398748A3 (fr) | 1991-10-23 |
CA2017157A1 (fr) | 1990-11-18 |
EP0398748A2 (fr) | 1990-11-22 |
JP3698520B2 (ja) | 2005-09-21 |
NO914517D0 (no) | 1991-11-18 |
GEP20002164B (en) | 2000-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MC2188A1 (fr) | Diagnostic du nanbv:polynucleotides permettant de depister le virus de l'hepatite c | |
HU9300323D0 (en) | Nanbv type diagnostic procedures and polynucleotides applicables for indicating hepatitis c virus | |
ATE507312T1 (de) | Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen | |
AU3844095A (en) | New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents | |
RU93004904A (ru) | Способ обнаружения вируса гепатита с, набор, способ получения крови, реагент | |
SG50563A1 (en) | New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents | |
WO1992019743A3 (fr) | Sequences genomiques du virus de l'hepatite c utilisees en diagnostic et en therapeutique | |
ATE303597T1 (de) | Hcv mosaik antigen zusammensetzung |